These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 13262650)

  • 1. [Effect of 3-(1-phenylpropyl)-4-hydroxycoumarin (marcumar) on the functional, morphological and histochemical characteristics of blood platelets and megakaryocytes; experimental research].
    SALVI F; RICCI M
    Haematologica; 1955; 39(6):425-40. PubMed ID: 13262650
    [No Abstract]   [Full Text] [Related]  

  • 2. Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant.
    BOURGAIN R; TODD M; HERZIG L; WRIGHT IS
    Circulation; 1954 Nov; 10(5):680-4. PubMed ID: 13209748
    [No Abstract]   [Full Text] [Related]  

  • 3. New anticoagulant for oral use-3-(1'-phenylpropyl)-4 hydroxycoumarin (liquamar); its evaluation for short-term therapy.
    GOLD H; LILLEY GW
    J Am Med Assoc; 1959 Jul; 170(11):1303-6. PubMed ID: 13664522
    [No Abstract]   [Full Text] [Related]  

  • 4. [Marcumar, 3-1-phenylpropyl-4-oxy-coumarin, a new superdicumarol].
    MATIS P
    Arztl Forsch; 1953 Jun; 7(6):I/298-302. PubMed ID: 13091939
    [No Abstract]   [Full Text] [Related]  

  • 5. [PAPER CHROMATOGRAPHIC DEMONSTRATION OF THE ANTICOAGULANTS 3-(1-PHENYLPROPYL)-4-HYDROXYCOUMARIN (FALITHROM) AND THE ETHYL ESTER OF DIHYDROXYCOUMARINYLACETIC ACID (PELENTAN)].
    FROST E; SEIDLEIN HJ
    Pharm Prax; 1964; 204():28-33. PubMed ID: 14235737
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ambulatory anticoagulant therapy with 3-(l-phenylpropyl)-4-hydroxycoumarin].
    KNOBEL P
    Praxis; 1956 Jan; 45(4):65-72. PubMed ID: 13310434
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new anticoagulant: 3-(1-phenylpropyl)4-hydroxycoumarin; early clinical results].
    VAN WIEN A; VEROFT R
    Acta Clin Belg; 1953; 8(6):618-28. PubMed ID: 13137838
    [No Abstract]   [Full Text] [Related]  

  • 8. [Coagulatory and histomorphological modifications induced by 3-(1-phenyl-propyl)-4-hydroxycoumarin; experimental study].
    SALVI F
    Riv Anat Patol Oncol; 1954 May; 8(4):569-602. PubMed ID: 13225432
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of 3-(1'-phenylpropyl)-4-hydroxycoumarin by means of high-performance liquid chromatography (HPLC) (author's transl)].
    Kinawi A
    Arzneimittelforschung; 1977 Feb; 27(2):360-3. PubMed ID: 577154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research on the effect of 4-hydroxycoumarin derivative G 23350 on Shwartzman-Sanarelli phenomenon].
    KAISER E; HERBST L
    Klin Med Osterr Z Wiss Prakt Med; 1956 Jan; 11(1):33-41. PubMed ID: 13320759
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticoagulant properties and therapeutic use of a new coumarin derivative: 3-[2-acetyl-1-(p-nitrophenol)-ethyl]-4-hydroxycoumarin or coumarin G 23350].
    LEROUX M; JAMAIN B
    Therapie; 1956; 11(1):85-101. PubMed ID: 13337762
    [No Abstract]   [Full Text] [Related]  

  • 12. Spectroscopic study of the interaction of coumarin anticoagulant drugs with polyvinylpyrrolidone.
    Otagiri M; Imai T; Koinuma H; Matsumoto U
    J Pharm Biomed Anal; 1989; 7(8):929-35. PubMed ID: 2490102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The possible tautomeric forms of 4-hydroxycoumarin].
    KLOSA J
    Arch Pharm Ber Dtsch Pharm Ges; 1953; 23(1):37-43. PubMed ID: 13066059
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyaluronidase-like effect of marcumar in vivo].
    SALVI F; MENTASTI P
    Gazz Med Ital; 1956 Jan; 115(1):12-8. PubMed ID: 13305785
    [No Abstract]   [Full Text] [Related]  

  • 15. [Derivative of 4-hydroxycoumarin as a new anticoagulant].
    KLOSA J
    Pharmazie; 1954 Aug; 9(8):622. PubMed ID: 13224346
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical data on anticoagulant treatment with 3-(1-phenylpropy1)-4-hydroxycoumarin].
    VERGANI G
    Gazz Med Ital; 1955 Dec; 114(12):269-73. PubMed ID: 13305779
    [No Abstract]   [Full Text] [Related]  

  • 17. The secretion of 3,3'-ethylidene bis (4-hydroxycoumarin) in milk.
    FANTL P; NELSON JF
    Med J Aust; 1952 Mar; 1(12):404-5. PubMed ID: 14918772
    [No Abstract]   [Full Text] [Related]  

  • 18. [Note on the condensation product between 4-hydroxycoumarin and thionylchloride].
    KLOSA J
    Arch Pharm Ber Dtsch Pharm Ges; 1953; 286(7):348-9. PubMed ID: 13125519
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of naproxen on the thrombocyte bleeding time and on the anticoagulant treatment with phenprocoumon].
    Angelkort B
    Fortschr Med; 1978 Jun; 96(23):1249-52. PubMed ID: 658877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibiting effect of heparin on hyaluronidase-like effect of marcumar].
    SALVI F
    Minerva Med; 1956 Jan; 47(9):276-80. PubMed ID: 13309003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.